This inventor holds 2 USPTO granted patents. Top assignee: Biomerieux, Inc.. Active years: 1996-1998.
Location History:
- Geneva, CH (1996)
- Geneve, CH (1998)
Company Filing History:
Years Active: 1996-1998
Title: Innovations of Jean-Claude Pechere in Mycobacterial Research
Introduction
Jean-Claude Pechere is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of mycobacterial research, particularly through his innovative patents. With a total of 2 patents, Pechere's work focuses on DNA fragments and amplification primers related to mycobacteria.
Latest Patents
Pechere's latest patents include groundbreaking work on DNA fragments of mycobacteria and amplification primers hybridization. One of his patents describes a nucleotide fragment of DNA that is included in the gene of the species of the genus Mycobacterium, coding for the 65-kD mycobacterial antigen. This fragment contains regions that are homologous in nearly all species of the genus Mycobacterium, along with at least one species-specific variable region. The patent specifies that the fragment is chosen from those whose nucleotide sequences possess at least 70% homology, and preferably at least 85% homology, with a predetermined sequence. This predetermined sequence begins at nucleotide 438 and ends at nucleotide 751 of the gene coding for the antigen of all species of mycobacteria, excluding certain species such as M. tuberculosis and M. bovis BCG.
Career Highlights
Jean-Claude Pechere is currently associated with bioMérieux, Inc., a company known for its expertise in diagnostics and microbiology. His work at bioMérieux has allowed him to further his research and contribute to advancements in the understanding of mycobacterial diseases.
Collaborations
Pechere collaborates with Claude Mabilat, a fellow researcher in the field. Their partnership has fostered innovation and development in mycobacterial research.
Conclusion
Jean-Claude Pechere's contributions to mycobacterial research through his patents and work at bioMérieux highlight his role as a significant inventor in the field. His innovative approaches continue to advance our understanding of mycobacterial diseases and diagnostics.